IceCure Medical Ltd
ICCM
$1.01
-$0.01-0.98%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | 3.60% | 7.02% | 4.67% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 3.60% | 7.02% | 4.67% | |
| Cost of Revenue | -- | 8.27% | 17.24% | 17.62% | |
| Gross Profit | -- | -2.61% | -6.16% | -10.03% | |
| SG&A Expenses | -- | -7.35% | -4.07% | -5.05% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -7.98% | -4.08% | -5.14% | |
| Operating Income | -- | 10.30% | 6.16% | 6.95% | |
| Income Before Tax | -- | 12.65% | 11.08% | 13.70% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | 12.65% | 11.08% | 13.70% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | 12.65% | 11.08% | 13.70% | |
| EBIT | -- | 10.30% | 6.16% | 6.95% | |
| EBITDA | -- | 10.69% | 6.60% | 7.51% | |
| EPS Basic | -- | 23.41% | 24.96% | 30.03% | |
| Normalized Basic EPS | -- | 32.52% | 33.82% | 33.82% | |
| EPS Diluted | -- | 23.41% | 24.96% | 30.03% | |
| Normalized Diluted EPS | -- | 32.52% | 33.82% | 33.82% | |
| Average Basic Shares Outstanding | -- | 12.87% | 17.08% | 23.29% | |
| Average Diluted Shares Outstanding | -- | 12.87% | 17.08% | 23.29% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |